Patient Recruitment Services Market Projected to Grow to USD 5.3 Billion by 2030, Predicts Roots Analysis
LONDON, March 28, 2019 /PRNewswire/ -- Roots Analysis has announced the addition of "Patient Recruitment and Retention Services Marker, 2019-2030" report to its list of offerings.
https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg
Pemba Lahmo, the principal analyst, stated, "A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different geographies and therapeutic indications."
The report presents opinions on several key aspects of the market. Among other elements, it includes:
-- A detailed assessment of the current market landscape of over 135
companies offering patient recruitment and retention services, including
information on over 10 types of patient outreach methods, types of
services offered ([A] patient recruitment (including pre-screening and
Institutional Review Board (IRB) / Ethics Committee (EC) submission),
[B] patient retention (considering various strategies, such as the use
of study-branded gifts, study-branded reminders, providing education and
support materials, reimbursement programs, transportation programs,
patient engagement web site, patient reconnect programs, mobile
applications to track patient engagement and others) and [C] other
associated services (including site identification and selection, study
feasibility / protocol development, project management, clinical trial
monitoring and other services), year of establishment, geographical
location, and size of company. The market landscape is fragmented,
featuring a mix of small-sized (less than 50 employees, 69%), mid-sized
(51-200 employees, 14%), and large-sized (more than 200 employees, 17%)
companies. Examples of large-sized players engaged in this domain
include (in alphabetical order, no selection criteria) Accelovance,
Bioclinica, BMC Group, CROee, IQVIA, Klick Health, Synexus, Syneos
Health and WCCT Global. On the other hand, examples of players that have
recently (since 2015) entered the market include (in alphabetical order,
no selection criteria) Access Clinical Research (2017), Clinically Media
(2017), Orphanos (2017), Splash Clinical (2016), CarthagoPharma (2016),
Clinspire Research (2016), Akcelis (2015) and PatientEvolution (2015).
-- An analysis of the most active regions (in terms of patient recruitment
activity) based on the locations of headquarters of companies engaged in
this domain, featuring schematic world map representations that
highlight key hubs across the globe. Majority of the aforementioned
service providers (80%) are based in North America and Europe. However,
a growing proportion of such companies are presently emerging in the
Asia-Pacific and other developing regions of the world. Examples of
companies based in the latter regions include (in alphabetical order, no
selection criteria) Clinical Trial Connect (CTC), Clinical Trial Group,
nRollmed, S4 Research, SitePartner, TrialWire and RemediumOne.
Specifically, around 35 companies provide their services globally.
Examples of some of these players include (in alphabetical order, no
selection criteria) Antidote, Bioclinica, Clariness, ClinicalConnection,
PAREXEL, ThreeWire, and WCCT Global.
-- An insightful 2X2 representation of the results of a competitiveness
analysis of various service providers (segregated into three peer groups
based on their employee count (small-sized (1-50 employees), mid-sized
(50-200 employees) and large (>200 employees)), highlighting capable
players in this domain, based on their respective capabilities. It is
worth highlighting that, close to 80% of the services providers claim to
offer patient recruitment specific services, such as project management,
assistance in institutional review board (IRB) / ethics committee (EC)
submissions, core CRO services, site management, clinical trial
monitoring, trial master file management, conducting meetings for staff
/ patients, and investigator grant management. Over 75 companies claim
to provide patient retention services. In addition, more than 70 firms
mention that cardiovascular, CNS and mental health disorders are their
primary focus areas. Other therapeutic areas for which patient
recruitment services are presently offered include (in decreasing order
of number of associated service providers) oncological disorders,
gastrointestinal disorders, respiratory disorders, autoimmune disorders,
infectious diseases, musculoskeletal disorders, metabolic disorders, eye
disorders, and rare diseases. It is also worth highlighting that 30
companies claim to provide services for recruiting patients in trials
evaluating medical devices.
-- Comprehensive profiles of patient recruitment and retention service
providers, featuring information on the location of their headquarters,
year of establishment, patient recruitment services / platforms
portfolio, recent developments and an informed future outlook.
-- An analysis of the partnerships that have been established during the
period 2013-2018, covering outsourcing agreements, service alliances,
acquisitions, joint ventures, mergers, technology licensing and
development agreements, and other forms of partnerships. Most of the
aforementioned deals were service alliances (34%), signed between
companies to combine their respective capabilities to offer an expanded
portfolio of services to their clients. Outsourcing agreements were the
second most popular type, representing 30% of the total number of deals.
Recent examples of outsourcing agreements include partnerships between
Synexus and University of Exeter (2018), CROee and Pfizer (2018), and
Foundation Medicine and European Organization for Research and Treatment
of Cancer (2018). These were followed by acquisitions (20%), mergers
(6%), technology development / licensing agreements (4%), joint ventures
(3%), and other agreements (2%).
-- A review of emerging trends in the industry, including the use of social
media, mobile technologies, EHRs and RWE, to overcome the challenges
associated with patient recruitment and retention. During our research,
we identified that more than 60% of the players claim to use social
media platforms to enroll patients for clinical studies. Further,
traditional broadcasting platforms, including TV, radio and newspaper,
constitute the second most popular medium for patient outreach
campaigns, being utilized by 41% of stakeholders in this domain. Other
popular outreach methods include print advertisement (32%), patient
advocacy groups (32%), physician referrals (30%), cold call / call
center (28%), patient networks (27%), proprietary patient databases
(27%), direct mail / e-mail (24%), and EMRs / pharmacy / health care
data (14%).
-- A detailed market forecast analysis, based on several parameters,
offering an informed perspective on the likely evolution of this market
over the period 2019-2030. The future opportunity was segmented across
[A] key therapeutic areas (oncology, infectious diseases, cardiovascular
diseases, CNS disorders, respiratory disorders, metabolic disorders, and
others), [B] steps in the patient recruitment process (pre-screening and
screening), [C] phases of development (phase I, phase II, phase III and
phase IV), and [D] different global regions (North America, Europe,
Asia-Pacific and rest of the world). Driven by the steady growth in the
volume of clinical trials, the patient recruitment services market is
expected to grow at an annualized rate of nearly ~4% between 2019 and
2030. Based on the aforementioned estimates, clinical trials evaluating
drugs for cancer indications are expected to contribute to 23% of the
revenues generated within the market by 2030; this is likely to be
followed by trials evaluating therapies for infectious diseases (15%),
cardiovascular diseases (15%), CNS disorders (10%), respiratory
disorders (7%), metabolic disorders (6%), and other indications (24%).
The report features inputs from a number of eminent industry stakeholders. Lahmo remarked, "Most of the experts we spoke to concur on the opinion that the rate of outsourcing of patient recruitment operations is likely to increase at a fast pace due to steady rise in global clinical trials, demand for highly specific study participants, and complex inclusion-exclusion criteria. In fact, some stakeholders expect close to 40% of such operations to be outsourced in the future." The report features detailed transcripts of discussions held with the following experts:
-- Simon Klaasen (Co-founder and Managing Director, Link2Trials)
-- Hagit Nof (Chief Operation Officer and Business Development, nRollmed)
-- Paul Ivsin (Managing Director, Seeker Health)
The research covers detailed profiles and assesses product portfolios of several companies, including (illustrative list, may not be comprehensive):
-- Acurian
-- Antidote
-- BBK Worldwide
-- Bright Pharmaceuticals Services
-- ClinEdge
-- CSSi
-- CTM
-- FIDELIS RESEARCH
-- Ignite Data
-- Integrated Clinical Trial Services
-- MMG
-- Polaris BioPharma Consulting
-- Raremark
-- TrialWire
-- WCCT Global
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html or email sales@rootsanalysis.com
Contact:
Gaurav Chaudhary
+1 (415) 800-3415
+44 (122) 391-1091
gaurav.chaudhary@rootsanalysis.com
View original content:http://www.prnewswire.com/news-releases/patient-recruitment-services-market-projected-to-grow-to-usd-5-3-billion-by-2030--predicts-roots-analysis-300820072.html
SOURCE Roots Analysis
